US5691181A
(en)
*
|
1984-08-21 |
1997-11-25 |
Celltech Limited |
DNA encoding lipase from human gastric mucosal tissue
|
EP0193112A3
(en)
*
|
1985-02-22 |
1987-02-25 |
The Trustees Of Columbia University In The City Of New York |
Cdna encoding mammalian insulin-like growth factor ii
|
US5242811A
(en)
*
|
1985-03-26 |
1993-09-07 |
Biogen, Inc. |
Production of human somatomedin C
|
AU6104586A
(en)
*
|
1985-08-12 |
1987-02-19 |
Malcolm A. Martin |
Aids protein using trple gene
|
EP0213472A1
(en)
*
|
1985-08-12 |
1987-03-11 |
Syntex (U.S.A.) Inc. |
Method for producing fusion proteins
|
AU6104686A
(en)
*
|
1985-08-12 |
1987-02-19 |
Syntex (U.S.A.) Inc. |
Bovine growth hormone releasing factor perivative
|
US5496924A
(en)
*
|
1985-11-27 |
1996-03-05 |
Hoechst Aktiengesellschaft |
Fusion protein comprising an interleukin-2 fragment ballast portion
|
US5359035A
(en)
*
|
1985-12-21 |
1994-10-25 |
Hoechst Aktiengesellschaft |
Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF)
|
US5019559A
(en)
*
|
1986-11-14 |
1991-05-28 |
President And Fellows Of Harvard College |
Wound healing using PDGF and IGF-II
|
US4861757A
(en)
*
|
1986-11-14 |
1989-08-29 |
Institute Of Molecular Biology |
Wound healing and bone regeneration using PDGF and IGF-I
|
US5270180A
(en)
*
|
1986-12-31 |
1993-12-14 |
Lucky, Ltd. |
Method for the production of salmon growth hormone using a synthetic gene
|
US5200509A
(en)
*
|
1987-04-06 |
1993-04-06 |
Celtrix Pharmaceuticals, Inc. |
Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
|
US5084384A
(en)
*
|
1987-04-23 |
1992-01-28 |
Monsanto Company |
Secretion of insulin-like growth factor-I
|
US5256644A
(en)
*
|
1988-05-20 |
1993-10-26 |
Institute Of Molecular Biology, Inc. |
Wound healing using IGF-II and TGF
|
US4983581A
(en)
*
|
1988-05-20 |
1991-01-08 |
Institute Of Molecular Biology, Inc. |
Wound healing composition of IGF-I and TGF-β
|
DE3834079A1
(de)
*
|
1988-10-06 |
1990-04-12 |
Biotechnolog Forschung Gmbh |
Wachstumstimulierendes pdgf-bb und dessen verwendung sowie ein verfahren zu seiner herstellung und der des monomeren
|
IL92816A0
(en)
*
|
1988-12-22 |
1990-09-17 |
Biogrowth Inc |
Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides
|
JPH0722517B2
(ja)
*
|
1989-08-24 |
1995-03-15 |
株式会社三和化学研究所 |
モチリン様ポリペプチドの製法並びにそのための組換えdna及び発現用プラスミド
|
WO1990010069A1
(en)
*
|
1989-02-28 |
1990-09-07 |
Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr |
RECOMBINANT PLASMID DNA pAA 1213-23 AND pAC 262-33 CODING FOR SYNTHESIS OF HUMAN INTERLEUKIN-2, METHOD OF THEIR CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI RRI/pAC 262-33 AS PRODUCER OF HUMAN INTERLEUKIN-2
|
USRE37919E1
(en)
|
1989-05-12 |
2002-12-03 |
The General Hospital Corporation |
Recombinant DNA method for production of parathyroid hormone
|
US5171670A
(en)
*
|
1989-05-12 |
1992-12-15 |
The General Hospital Corporation |
Recombinant dna method for production of parathyroid hormone
|
GB8927008D0
(en)
*
|
1989-11-29 |
1990-01-17 |
Ciba Geigy |
Novel process for the production of unfused protein in e.coli
|
ATE222117T1
(de)
*
|
1990-05-30 |
2002-08-15 |
Harvard College |
Kombination aus igf-i und tgf-beta zur knochenregenerierung
|
JP4236698B2
(ja)
|
1990-11-26 |
2009-03-11 |
ジェネティックス インスティチュート,リミテッド ライアビリティ カンパニー |
宿主細胞でのpaceの発現およびその使用法
|
SE9100099D0
(sv)
*
|
1991-01-11 |
1991-01-11 |
Kabi Pharmacia Ab |
Use of growth factor
|
US5589452A
(en)
*
|
1992-07-14 |
1996-12-31 |
Syntex (U.S.A.) Inc. |
Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
|
US5977070A
(en)
*
|
1992-07-14 |
1999-11-02 |
Piazza; Christin Teresa |
Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
|
US5464934A
(en)
*
|
1993-05-14 |
1995-11-07 |
Mallinckrodt Medical, Inc. |
Metal chelates as spacer compounds in biologically active peptides
|
US5407810A
(en)
*
|
1993-08-20 |
1995-04-18 |
Genentech, Inc. |
Aqueous multiple-phase isolation of polypeptide
|
US5663304A
(en)
*
|
1993-08-20 |
1997-09-02 |
Genentech, Inc. |
Refolding of misfolded insulin-like growth factor-I
|
US5446024A
(en)
*
|
1993-12-17 |
1995-08-29 |
Genentech, Inc. |
Purification of insulin-like growth factor
|
US5629167A
(en)
|
1994-04-19 |
1997-05-13 |
Biocine S.P.A. |
Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
|
EP0779927A1
(en)
*
|
1994-09-08 |
1997-06-25 |
Chiron Corporation |
A method of improved production of insulin-like growth factor
|
US5728676A
(en)
*
|
1994-09-08 |
1998-03-17 |
Ciba-Geigy Corporation |
Use of insulin-like growth factors I and II for inhibition of inflammatory response
|
US6117651A
(en)
*
|
1996-11-08 |
2000-09-12 |
Neose Technologies, Inc. |
Expression vectors
|
ES2293662T3
(es)
*
|
1996-11-15 |
2008-03-16 |
Genentech, Inc. |
Purificacion de neurotrofinas.
|
US6265542B1
(en)
|
1997-10-24 |
2001-07-24 |
Genentech, Inc. |
Purification of molecules
|
CA2671261A1
(en)
|
1997-11-06 |
1999-05-20 |
Novartis Vaccines And Diagnostics S.R.L. |
Neisserial antigens
|
DE69941567D1
(de)
|
1998-01-14 |
2009-12-03 |
Novartis Vaccines & Diagnostic |
Antigene aus neisseria meningitidis
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
EP2261338A3
(en)
|
1998-05-01 |
2012-01-04 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria meningitidis antigens and compositions
|
ES2397918T3
(es)
|
1999-04-30 |
2013-03-12 |
Novartis Vaccines And Diagnostics S.R.L. |
Antígenos Neisseriales conservados
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
CN101613397A
(zh)
|
1999-10-29 |
2009-12-30 |
启龙股份公司 |
奈瑟球菌的抗原性肽
|
ES2507100T3
(es)
|
2000-01-17 |
2014-10-14 |
Novartis Vaccines And Diagnostics S.R.L. |
Vacuna OMV suplementada contra meningococo
|
FR2810675B1
(fr)
*
|
2000-06-22 |
2002-09-27 |
Pf Medicament |
Construction modifiee en aval du codon d'initiation pour la surexpression de proteines recombinantes
|
KR20030046411A
(ko)
*
|
2000-09-08 |
2003-06-12 |
그리폰 테라퓨틱스, 인코포레이티드 |
'위'-천연 화학적 라이게이션
|
AU1412702A
(en)
|
2000-10-27 |
2002-05-06 |
Chiron Spa |
Nucleic acids and proteins from streptococcus groups a and b
|
US6716602B2
(en)
|
2000-11-03 |
2004-04-06 |
Genentech, Inc. |
Metabolic rate shifts in fermentations expressing recombinant proteins
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
AU2002355197A1
(en)
|
2001-07-27 |
2003-02-17 |
Chiron Srl |
Meningococcus adhesins nada, app and orf 40
|
EP2335724A1
(en)
|
2001-12-12 |
2011-06-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Immunisation against chlamydia trachomatis
|
WO2003099848A2
(en)
*
|
2002-05-24 |
2003-12-04 |
Restoragen Inc. |
Method for universal enzymatic production of bioactive peptides
|
DE60330564D1
(de)
|
2002-05-24 |
2010-01-28 |
Restoragen Inc |
Verfahren und konstrukte zur expression von clostripain mit hoher ausbeute
|
EP1554302A4
(en)
*
|
2002-05-24 |
2006-05-03 |
Restoragen Inc |
DNA RECOMBINATION METHODS AND PRODUCTS FOR HIGH-YIELD PRODUCTION OF POLYPEPTIDES
|
CA2485701A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Fred W. Wagner |
Method for enzymatic production of glp-1 (7-36) amide peptides
|
WO2003099854A2
(en)
*
|
2002-05-24 |
2003-12-04 |
Nps Allelix Corp. |
Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
|
EP1562982B1
(en)
|
2002-11-15 |
2010-05-05 |
Novartis Vaccines and Diagnostics S.r.l. |
Unexpected surface proteins in neisseria meningitidis
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
EP2392581A3
(en)
|
2003-04-25 |
2012-03-07 |
North Carolina State University |
Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
|
US7407787B2
(en)
|
2003-06-23 |
2008-08-05 |
North Carolina State University |
Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
|
ME01366B
(me)
*
|
2003-11-21 |
2013-12-20 |
Nps Allelix Corp |
POSTUPAK ZA PROIZVODNJU PEPTIDA 2 NALIK NA GLUKAGON l NJIHOVIH ANALOGA
|
MXPA06008506A
(es)
|
2004-02-02 |
2007-01-30 |
Ambrx Inc |
Polipeptidos de hormona de crecimiento humana modificada y sus usos.
|
US7459289B2
(en)
|
2004-03-08 |
2008-12-02 |
North Carolina State University |
Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
|
AU2005265163B2
(en)
*
|
2004-06-18 |
2009-10-01 |
Ambrx, Inc. |
Novel antigen-binding polypeptides and their uses
|
AU2005327906B2
(en)
*
|
2004-07-21 |
2010-05-13 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
JP5425398B2
(ja)
|
2004-12-22 |
2014-02-26 |
アンブレツクス・インコーポレイテツド |
非天然アミノ酸及びポリペプチドを含む組成物、非天然アミノ酸及びポリペプチドに関連する方法並び非天然アミノ酸及びポリペプチドその使用
|
EP1836298B1
(en)
*
|
2004-12-22 |
2012-01-18 |
Ambrx, Inc. |
COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF
|
NZ555206A
(en)
*
|
2004-12-22 |
2010-09-30 |
Ambrx Inc |
Methods for expression and purification of recombinant human growth hormone
|
CA2592390A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Genentech, Inc. |
Methods for producing soluble multi-membrane-spanning proteins
|
US7816320B2
(en)
|
2004-12-22 |
2010-10-19 |
Ambrx, Inc. |
Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
|
MX2007007580A
(es)
|
2004-12-22 |
2007-12-11 |
Ambrx Inc |
Hormona del crecimiento humana modificada.
|
BRPI0610609A2
(pt)
|
2005-04-15 |
2010-07-06 |
Univ North Carolina State |
métodos e composições para modular a adesão e toleráncia ao estresse em bactérias
|
JP2008541769A
(ja)
*
|
2005-06-03 |
2008-11-27 |
アンブレツクス・インコーポレイテツド |
改善されたヒトインターフェロン分子及びそれらの使用
|
ES2408581T3
(es)
*
|
2005-08-18 |
2013-06-21 |
Ambrx, Inc. |
Composiciones de ARNt y usos de las mismas
|
RS51998B
(en)
*
|
2005-11-08 |
2012-04-30 |
Ambrx Inc. |
ACCELERATORS FOR MODIFICATION OF NON-NATURAL AMINO ACIDS AND NON-NATURAL AMINO ACID POLYPEPTIDES
|
EP1951890A4
(en)
*
|
2005-11-16 |
2009-06-24 |
Ambrx Inc |
PROCESSES AND COMPOSITIONS WITH NON-NATURAL AMINO ACIDS
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
CN101448512B
(zh)
*
|
2005-12-14 |
2015-11-25 |
Ambrx公司 |
含有非天然氨基酸和多肽的组合物、涉及非天然氨基酸和多肽的方法以及非天然氨基酸和多肽的用途
|
EP2035035A2
(en)
|
2006-06-09 |
2009-03-18 |
Novartis AG |
Immunogenic compositions for streptococcus agalactiae
|
US20080119433A1
(en)
*
|
2006-07-06 |
2008-05-22 |
Aaron Thomas Tabor |
Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
|
KR20090060294A
(ko)
|
2006-09-08 |
2009-06-11 |
암브룩스, 인코포레이티드 |
변형된 인간 혈장 폴리펩티드 또는 Fc 스캐폴드 및 그의 용도
|
SG174788A1
(en)
*
|
2006-09-08 |
2011-10-28 |
Ambrx Inc |
Suppressor trna transcription in vertebrate cells
|
ES2457527T3
(es)
*
|
2006-09-08 |
2014-04-28 |
Ambrx, Inc. |
ARNt Supresor hibrido en células de vertebrados
|
PL2068909T3
(pl)
|
2007-03-30 |
2012-09-28 |
Ambrx Inc |
Modyfikowane polipeptydy fgf-21 i ich zastosowanie
|
CA2685596A1
(en)
*
|
2007-05-02 |
2008-11-13 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
KR101656107B1
(ko)
|
2007-11-20 |
2016-09-08 |
암브룩스, 인코포레이티드 |
변형된 인슐린 폴리펩티드 및 이의 용도
|
EP3103880A1
(en)
|
2008-02-08 |
2016-12-14 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
EP2886551A3
(en)
|
2008-02-21 |
2015-09-23 |
Novartis AG |
Meningococcal fhbp polypeptides
|
MX2011000859A
(es)
*
|
2008-07-23 |
2011-02-24 |
Ambrx Inc |
Polipeptidos g-csf bovinos modificados y sus usos.
|
MX346001B
(es)
|
2008-09-26 |
2017-03-01 |
Ambrx Inc |
Polipeptidos de eritropoyetina animal modificados y sus usos.
|
TR201802361T4
(tr)
|
2008-09-26 |
2018-03-21 |
Ambrx Inc |
Doğal olmayan amino asit replikasyonuna bağımlı mikroorganizmalar ve aşılar.
|
WO2011008904A1
(en)
|
2009-07-17 |
2011-01-20 |
Tabor Aaron T |
Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
|
NZ598458A
(en)
|
2009-08-27 |
2014-03-28 |
Novartis Ag |
Hybrid polypeptides including meningococcal fhbp sequences
|
CN102917730A
(zh)
|
2009-10-27 |
2013-02-06 |
诺华有限公司 |
修饰的脑膜炎球菌fHBP多肽
|
BR112012015461A2
(pt)
|
2009-12-21 |
2017-01-10 |
Ambrx Inc |
polipeptídeos de somatotropina boviina modificados e seus usos
|
CN104017063A
(zh)
|
2009-12-21 |
2014-09-03 |
Ambrx公司 |
经过修饰的猪促生长素多肽和其用途
|
JP5871911B2
(ja)
|
2010-05-19 |
2016-03-01 |
ノース カロライナ ステート ユニバーシティ |
治療用ペプチドの送達のための組成物および方法
|
MY162837A
(en)
|
2010-08-17 |
2017-07-31 |
Ambrx Inc |
Modified relaxin polypeptides and their uses
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
EP3060656A1
(en)
|
2013-10-24 |
2016-08-31 |
Yeda Research and Development Co., Ltd. |
Polynucleotides encoding brex system polypeptides and methods of using same
|
CN107108710B
(zh)
|
2014-10-24 |
2022-02-15 |
百时美施贵宝公司 |
修饰的fgf-21多肽及其用途
|
US10590426B2
(en)
|
2016-08-22 |
2020-03-17 |
Board Of Trustees Of Michigan State University |
Genetic control of cell size
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
US10266578B2
(en)
|
2017-02-08 |
2019-04-23 |
Bristol-Myers Squibb Company |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
CA3111576A1
(en)
|
2018-09-11 |
2020-03-19 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and their uses
|
US20220175807A1
(en)
|
2019-03-31 |
2022-06-09 |
Yeda Research And Development Co. Ltd. |
Anti-viral and anti-tumoral compounds
|
AU2021233909A1
(en)
|
2020-03-11 |
2022-09-29 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and methods of use thereof
|
IL288680A
(en)
|
2021-12-05 |
2023-07-01 |
Yeda Res & Dev |
Genetically modified phages and their use
|